In vitro and in silico evaluation of antiretrovirals against SARS-CoV-2: A drug repurposing approach
Background: Drug repurposing is a valuable strategy for rapidly developing drugs for treating COVID-19. This study aimed to evaluate the antiviral effect of six antiretrovirals against SARS-CoV-2 in vitro and in silico. Methods: The cytotoxicity of lamivudine, emtricitabine, tenofovir, abacavir...
Main Authors: | Maria I. Zapata-Cardona, Lizdany Florez-Alvarez, Ariadna L. Guerra-Sandoval, Mateo Chvatal-Medina, Carlos M. Guerra-Almonacid, Jaime Hincapie-Garcia, Juan C. Hernandez, Maria T. Rugeles, Wildeman Zapata-Builes |
---|---|
Format: | Article |
Language: | English |
Published: |
AIMS Press
2023-01-01
|
Series: | AIMS Microbiology |
Subjects: | |
Online Access: | https://www.aimspress.com/article/doi/10.3934/microbiol.2023002?viewType=HTML |
Similar Items
-
Evolution of Antiretroviral Drug Rilpivirine and Approach to Oncology
by: Mariana Pereira, et al.
Published: (2023-02-01) -
Neutralizing antibody titers to Omicron six months after vaccination with BNT162b2 in Colombia
by: María I. Zapata-Cardona, et al.
Published: (2022-12-01) -
Rocio Virus Encephalitis: In Silico Evidence for Drug Repurposing
by: João Pedro Sagini, et al.
Published: (2022-02-01) -
Ligand-Based and Structured-Based In Silico Repurposing Approaches to Predict Inhibitors of SARS-CoV-2 Mpro Protein
by: Alfredo Juárez-Saldívar, et al.
Published: (2020-11-01) -
Targeting envelope proteins of poxviruses to repurpose phytochemicals against monkeypox: An in silico investigation
by: Pallavi Gulati, et al.
Published: (2023-01-01)